FDA Advisory No.2023-2539 || Pilot Implementation of the Food and Drug Administration eServices Portal System for License to Operate Application of Food Manufacturers within National Capital Region
The Food and Drug Administration (FDA) continues its digital system enhancement through the development of online application platforms including the eServices Portal System. This intends to simplify the process of […]
FDA Advisory No.2023-2538 || Common Services Laboratory (CSL) Submission Holiday
To ensure continuous improvement of its services, the CSL will conduct its inventory of pending requests for analysis and regular equipment system maintenance starting 27 December 2023 until 12 January […]
FDA Advisory No.2023-2534 || End of Pilot Implementation of the Food and Drug Administration eServices Portal System for License to Operate Application of Drug Manufacturers from the Selected Regions
The Food and Drug Administration hereby notify the general public and all drug manufacturers, packers, and repackers from the following regions that the pilot implementation for License to Operate application […]
FDA Advisory No.2023-2401 || COMMON SERVICES LABORATORY CY 2023 YEAR-END PROGRAM IMPLEMENTATION REVIEW (PIR)
To assess the performance of the laboratory against the predetermined objectives and benchmarks, thereby providing insights into the laboratory’s intended outcomes and identifying areas for improvement for seamless processes, all […]
FDA Advisory No.2023-2328 || Updated Process Flow and Application Form for Food Export Certificate and/or Food Commodity Clearance
To further streamline and improve the delivery of service, the FDA, through the Common Services Laboratory (CSL), has updated the process flow (Annex A) and application form (Annex B) for […]
FDA Advisory No.2023-2238 || Utilization of the Food and Drug Administration (FDA) Verification Portal
Republic Act (RA) No. 9711 otherwise known as the “Food and Drug Administration Act of 2009” is promulgated to enhance and strengthen the administrative and technical capacity of the FDA […]
FDA Advisory No.2023-2154 || ADOPTION OF THE BAGONG PILIPINAS LOGO
Pursuant to Memorandum Circular No. 24 entitled “Launching the Bagong Pilipinas Campaign as the Administration’s Brand of Governance and Leadership” which was issued by the Office of the President on […]
FDA Advisory No.2023-1932 || RELEASING OF APPROVED PROMO PERMIT APPLICATION
The Food and Drug Administration is committed to following the guidelines outlined in Presidential Proclamation No. 297 s. 2023, which pertains to the lifting of the state of public health […]
FDA Advisory No.2023-1925 || Call for Nomination as member of the Clinical Trial Scientific Advisory Committee (SAC)
Pursuant to Republic Act No. 9711, otherwise known as the “Food and Drug Administration (FDA) Act of 2009”, the FDA shall have the function to supervise, monitor and audit research […]
FDA Advisory No.2023-1924 || Call for Nomination as member of the Pharmacovigilance Advisory Committee (PVAdCom)
Pursuant to Republic Act No. 9711, otherwise known as the “Food and Drug Administration (FDA) Act of 2009”, the FDA shall have the function to institute and strengthen the post […]